Mirum Pharmaceuticals Inc. (MIRM) Fundamentals

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
SHARE INFORMATION
Market Cap$ 684,682,957
Shares Outstanding36,870,380
Float23,002,675
Percent Float62.39%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 19,138,000
Latest Fiscal EPS$ -2.77
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions268
Institutional Holdings Date2022-10-31
Institutional Bought Previous 3 Months5,127,639
Institutional Holdings Percent107.7%
Institutional Sold Previous 3 Months2,742,341
Insider Holdings Date2022-10-31
Insider Bought Previous 3 Months-
Insider Holdings Percent0.8
Insider Sold Previous 3 Months-
Insider Shares Owned302,895
TRADING INFO
52 Week High$ 30.55
52 Week Low$ 12.82
52 Week High Change$ 42.30
21 Day Moving Average$ 20.8405
21 Day Extended Moving Average$ 20.2591
50 Day Moving Average$ 20.8018
50 Day Extended Moving Average$ 21.074
200 Day Moving Average$ 22.9072
200 Day Extended Moving Average$ 21.6772
10 Day Average Volume268,852
20 Day Average Volume332,368
30 Day Average Volume325,058
50 Day Average Volume380,689
Alpha0.047555
Beta1.4403
Standard Deviation0.425353
R20.038005
7 Day Price Change$ -1.14
7 Day Percent Change-5.78%
21 Day Price Change$ -5.37
21 Day Percent Change-22.43%
30 Day Price Change$ -5.26
30 Day Percent Change-22.07%
Month to Date Price Change$ -3.98
Month to Date Percent Change-17.65%
Quarter to Date Price Change$ -2.44
Quarter to Date Percent Change-11.61%
180 Day Price Change$ -6.19
180 Day Percent Change-25.0%
200 Day Price Change$ -5.43
200 Day Percent Change-22.63%
Year to Date Price Change$ 2.62
Year to Date Percent Change16.43%

Mirum Pharmaceuticals Inc. (MIRM) Key Ratios

PROFITABILITY
EBIT Margin-62.8%
EBITDA Margin-57.5%
Pre-Tax Profit Margin0.0%
Profit Margin Count-79.72%
Gross Margin81.3%
Profit Margin TOT-79.72%
INCOME STATEMENTS
Revenue$ 52,294,000
Revenue Per Share$ 1.4183
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book5.90
Total Debt To Equity0.00
Int Coverage-2.10
Current Ratio4.20
Leverage Ratio2.40
Quick Ratio3.90
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio-17.80
Enterprise Value$ 552,303,081
Price to Sales13.093
Price to Free Cash-5.30
PE High Last 5 Years0.00
Price To Book4.30
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book5.90
MANAGEMENT EFFECTIVENESS
Receivables Turnover6.20
Invoice Turnover2.80
Assets Turnover0.10
Return Assets-13.91
Return on Equity-36.94
Return on Capital-25.96

Mirum Pharmaceuticals Inc. (MIRM) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOChristopher Peetz
Emplyoees171
Last AuditUQ
CIK0001759425
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address950 Tower Lane
Suite 1050
Foster City, CA 94404
Websitehttps://www.mirumpharma.com
Facsimile-
Telephone+1 650 667-4085
Email-


Your Recent History
NASDAQ
MIRM
Mirum Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.